PLGA-mPEG, MW x 1K, n 2K provides a biodegradable amphiphilic block copolymer for polymer self-assembly and drug delivery research and specifically combines a 1 kDa poly(lactic-co-glycolic acid) (PLGA) block with a 2 kDa methoxy polyethylene glycol (mPEG) chain. Its PEG-rich composition supports investigations of polymer hydration, aqueous dispersion, and self-assembled nanostructures.
Key Features and Benefits
- 1 kDa PLGA Block: Provides a short biodegradable hydrophobic polyester segment for polymer self-assembly, drug encapsulation studies, and degradation research.
- 2 kDa mPEG Block: Introduces a hydrophilic PEG chain that specifically contributes to polymer hydration, aqueous compatibility, and dispersion properties.
- Amphiphilic Structure: Combines hydrophobic PLGA and hydrophilic mPEG segments to specifically support polymeric self-assembly under suitable formulation conditions.
- Biodegradable PLGA Segment: Contains hydrolytically degradable ester bonds that enable investigations of polymer degradation, molecular weight changes, and release behavior.
- PEG-Rich Composition: Features a nominal 1:2 PLGA-to-mPEG molecular weight ratio, providing approximately 66.7% PEG by combined block mass.
- Methoxy-Terminated PEG: Incorporates a methyl ether terminus without a dedicated reactive conjugation group, supporting preparation of PEG-containing polymeric materials.
- Hydrophilic Surface Functionality: Provides PEG chains that may influence polymer hydration, protein interactions, aggregation, and colloidal stability.
- Short Hydrophobic Segment: Enables investigation of how reduced PLGA chain length affects self-assembly, hydrophobic interactions, and drug encapsulation capacity.
- Formulation Versatility: Supports solvent exchange, nanoprecipitation, and emulsification methods for investigating polymeric nanoparticles and other self-assembled structures.
Applications
- Polymeric Micelle Research: Supports investigation of amphiphilic polymer self-assembly, micelle formation, and aggregation under suitable aqueous conditions.
- Nanoparticle Formulation Studies: Enables evaluation of PEG-rich polymer formulations and their ability to form stable nanoscale assemblies.
- Hydrophobic Drug Encapsulation: Supports screening of compatible, poorly water-soluble compounds for incorporation into PLGA-containing polymeric assemblies.
- Drug Delivery Research: Facilitates development and characterization of biodegradable amphiphilic polymers for experimental drug delivery systems.
- Polymer Self-Assembly Studies: Enables examination of concentration-dependent aggregation, molecular organization, and polymer behavior in aqueous environments.
- Aqueous Compatibility Research: Supports investigation of PEG-rich polymer hydration, solubility, and dispersion under different formulation conditions.
- Polymer Degradation Studies: Facilitates characterization of PLGA hydrolysis, molecular weight reduction, and changes in polymer properties over time.
- Nanoparticle Surface Engineering: Enables evaluation of PEG chain effects on surface hydration, protein interactions, aggregation, and colloidal stability.
- Polymer Composition Research: Supports comparisons of PLGA-to-PEG ratios and their effects on self-assembly, drug loading, and formulation performance.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and excessive heat. Follow product-specific storage instructions when available. Minimize humidity exposure to reduce premature PLGA hydrolysis.
- Handling: Handle using clean, dry equipment and dissolve in a compatible solvent, such as acetone, DMF, DMSO, or dichloromethane. Confirm solubility before selecting the formulation method.
- Investigate polymer self-assembly through solvent exchange, nanoprecipitation, or other suitable formulation methods. The nominal 1:2 PLGA-to-mPEG ratio provides approximately 66.7% PEG by combined block mass. This hydrophilic fraction may influence aqueous compatibility, self-assembly, drug loading, and dispersion behavior.
- Evaluate aggregation, particle size, dispersion stability, and drug loading using appropriate analytical techniques. The short PLGA block may limit hydrophobic core formation and encapsulation capacity. Avoid prolonged exposure to moisture, strong acids, and alkaline conditions. Confirm the PLGA lactide-to-glycolide ratio and polymer specifications before use.
PLGA-mPEG, MW x 1K, n 2K combines a short biodegradable PLGA block with a longer hydrophilic mPEG chain and specifically supports polymer self-assembly research, micelle studies, nanoparticle formulation, and biodegradable drug delivery investigations.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.